« Enzymes, Nanotech, and Picky, Picky Details |
| Four Billion Compounds At a Time »
August 21, 2012
Genentech's Big Worry: Roche?
There's no telling if this is true - it's part of a lawsuit. But a former Genentech employee is claiming that the company rushed trials of its PI3K inhibitor. And why? Worries about their partner:
The suit alleges that the Pi3 Kinase team was guilty of "illegal and unethical conduct" by skirting established scientific and ethical standards required of drug researchers. Juliet Kniley claims she complained in 2008 and then was sidelined in 2009 with a demotion after being instructed to push ahead on the study. And she says she was told twice that Roche would "take this molecule away from us" if they saw her proposed timelines.
Genentech denies the allegations. But you have to wonder if there's still a window here into the relationship between the two companies. . .
+ TrackBacks (0) | Category: Drug Development
POST A COMMENT
- RELATED ENTRIES
- How Not to Do It: NMR Magnets
- Allergan Escapes Valeant
- Vytorin Actually Works
- Fatalities at DuPont
- The New York TImes on Drug Discovery
- How Are Things at Princeton?
- Phage-Derived Catalysts
- Our Most Snorted-At Papers This Month. . .